Brief: Pharmaust Partners With Berry Consultants For Phase 2/3 MND Study
16/01/2024 24:15
Jan 16 (Reuters) - Pharmaust Ltd PAA.AX :
* PARTNERS WITH BERRY CONSULTANTS FOR PHASE 2/3 MND STUDY
Source text for Eikon: ID:nASX43l1Kw
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility